Both Labral Debridement and Labral Repair Result in >90% Total Hip Arthroplasty‐free Survival at 5‐Year Follow‐Up: An Analysis of the German Cartilage Registry (KnorpelRegister DGOU)
Arthroscopy · 2024-01 · 40 (1) · 81-90
DOI: 10.1016/j.arthro.2023.04.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthroscopy, online erschienen am 03.05.2023. Verfasst von Nils Wirries und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery at Diakovere Annastift, Hannover Medical School, Hanover; Germany. Electronic address: Nils.Wirries@diakovere.de. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Femoracetabular Impingement, Cartilage, Articular. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Purpose
To compare clinical outcome parameters between labral debridement and repair by analyzing the dataset of a multinational registry.
Methods
The data are based on the hip module of the German Cartilage Registry (KnorpelRegister DGOU). The register included patients designated for cartilage or femoroacetabular impingement surgery (up to July 1, 2021; n = 2725). The assessment consisted of the patient’s characteristics, the type of labral treatment, the length of labral therapy, the pathology, the grade of cartilage damage, and the type of performed approach. The clinical outcomes were documented by the international hip outcome tool via an online platform. Separated Kaplan–Meier analyses were used for total hip arthroplasty (THA)‐free survival rates.
Results
The debridement group (n = 673) showed a mean score increase of 21.9 ± 25.3 points. The repair group (n = 963) had a mean improvement of 21.3 ± 24.6 ( P > .05). The 60‐month THA‐free survival rate was 90% to 93% for both groups ( P > .05). A multivariance analysis showed that the grade of cartilage damage was the only independent statistically significant factor ( P = .002‐.001) influencing patients’ outcomes and THA‐free survival.
Conclusions
Labral debridement and repair led to good and reliable results. However, these results should not be interpreted with the conclusion that the cheaper and technically easier labral debridement is the recommended treatment due to comparable results in the present study. The clinical outcome and the THA‐free survival seemed to be more influenced by the grade of cartilage damage. Level of Evidence Level III, retrospective comparative therapeutic trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Orthopaedic Surgery at Diakovere Annastift, Hannover Medical School, Hanover; Germany. Electronic address: Nils.Wirries@diakovere.de.
- Orthoexpert, Knittelfeld, Austria.
- ARCUS Sportklinik, Pforzheim; Germany.
- Department of Orthopaedics and Orthopaedic Surgery, Saarland University Medical Center, Homburg; Germany.
- Orthopädische Chirurgie München (OCM), Munich, Germany.
- Sporthopaedicum, Straubing, Germany.
Zitieren
APA
Wirries, N., Zinser, W., Sobau, C., Landgraeber, S., Dienst, M., & Fickert, S. (2024). Both Labral Debridement and Labral Repair Result in >90% Total Hip Arthroplasty‐free Survival at 5‐Year Follow‐Up: An Analysis of the German Cartilage Registry (KnorpelRegister DGOU). Arthroscopy, 40(1), 81-90. https://doi.org/10.1016/j.arthro.2023.04.014
Vancouver
Wirries N, Zinser W, Sobau C, Landgraeber S, Dienst M, Fickert S. Both Labral Debridement and Labral Repair Result in >90% Total Hip Arthroplasty‐free Survival at 5‐Year Follow‐Up: An Analysis of the German Cartilage Registry (KnorpelRegister DGOU). Arthroscopy. 2024;40(1):81-90. doi:10.1016/j.arthro.2023.04.014
BibTeX
@article{Wirries2024,
author = {Wirries, Nils and Zinser, Wolfgang and Sobau, Christian and Landgraeber, Stefan and Dienst, Michael and Fickert, Stefan},
title = {Both Labral Debridement and Labral Repair Result in >90% Total Hip Arthroplasty‐free Survival at 5‐Year Follow‐Up: An Analysis of the German Cartilage Registry (KnorpelRegister DGOU)},
journal = {Arthroscopy},
year = {2024},
volume = {40},
number = {1},
pages = {81--90},
doi = {10.1016/j.arthro.2023.04.014}
}
EUVIMED